Donor-derived Cell-free DNA Kinetics Post-kidney Transplant Biopsy

Autor: Yousuf Kyeso, MD, Anshul Bhalla, MD, Alyssa P. Smith, BSc, Yaqi Jia, MPH, Safa Alakhdhair, MS, Stephanie C. Ogir, BA, Mohammad Abuzeineh, MD, Daniel C. Brennan, MD, Sami Alasfar, MD
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Zdroj: Transplantation Direct, Vol 7, Iss 6, p e703 (2021)
Druh dokumentu: article
ISSN: 2373-8731
00000000
DOI: 10.1097/TXD.0000000000001149
Popis: Background. Donor-derived cell-free DNA (dd-cfDNA) has generated interest as a biomarker for kidney injury including transplant (KT) rejection. It is possible that the KT biopsy procedure can cause the release of dd-cfDNA, therefore affecting the reliability of this assay in the postbiopsy period. We evaluated the effect of KT biopsy on the kinetics of dd-cfDNA. Methods. We conducted a single-arm prospective study. Samples were collected from 16 adult KT recipients undergoing KT biopsy. All participants had samples drawn within 8 h before the biopsy (prebiopsy), within 20 min (hour 0), 2 h (hour 2), and 24–48 h (hours 24–48) after the biopsy. We evaluated the change in dd-cfDNA from the prebiopsy time point to the following 3 time points after the biopsy. Results. At hour 0 and hour 2, there was a significantly larger log dd-cfDNA mean score compared with the prebiopsy score (least square mean estimate 0.4 [0.17-0.63] and 0.39 [0.09-0.68], respectively). By 24–28 h postbiopsy, there was no significant difference in log dd-cfDNA mean score compared with the prebiopsy score (least square mean estimate −0.21 [−0.6 to 0.19]). Conclusions. Mechanical injury from a KT biopsy can transiently increase circulating dd-cfDNA. The increase resolves by 24–48 h after the biopsy. Providers should wait 48 h postbiopsy to obtain dd-cfDNA levels to establish the correct baseline to be used for monitoring.
Databáze: Directory of Open Access Journals